30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
Switzerland Biotechnology & Medical Research

Basilea Pharmaceutica AG (BSLN)

Track

Over the last 90 days, Basilea Pharmaceutica AG has seen a net insider selling of CHF 272,355.95. A total of six sell transactions were recorded, with no buy transactions. This activity represents a net buy as a percentage of float of -0.0003%. The stock has experienced a -1.4% price change over the same period.
Stock chart
Ticker: BSLN Exchange: SWX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Unknown insider
1 sale — total 20,800 CHF
Sale 29 May 2026
Value CHF4,843,904.34 | Price 329.70 | Shares 46,674
Sale 13 May 2026
Value CHF3,083,877.41 | Price 446.26 | Shares 1,466
Sale 30 Apr 2026
Value CHF21,600.00 | Price 54.00 | Shares 400
Sale 20 Apr 2026
Value CHF56,400.00 | Price 56.40 | Shares 1,000
Sale 17 Apr 2026
Value CHF56,000.00 | Price 56.00 | Shares 1,000
Sale 15 Apr 2026
Value CHF15,600.00 | Price 10.40 | Shares 1,500
Sale 26 Feb 2026
Value CHF18,800.00 | Price 9.40 | Shares 2,000
Sale 24 Feb 2026
Value CHF10,800.00 | Price 7.20 | Shares 1,500
Sale 20 Feb 2026
Value CHF32,806.80 | Price 54.68 | Shares 600
Sale 24 Nov 2025
Value CHF28,920.00 | Price 48.20 | Shares 600
Sale 30 Sep 2025
Value CHF56,400.00 | Price 47.00 | Shares 1,200
Sale 21 May 2025
Value CHF27,000.00 | Price 45.00 | Shares 600
Sale 30 Apr 2025
Value CHF17,600.00 | Price 44.00 | Shares 400
Sale 23 Apr 2025
Value CHF57,396.20 | Price 41.93 | Shares 1,369
Sale 23 Apr 2025
Value CHF30,331.00 | Price 41.55 | Shares 730
Sale 17 Apr 2025
Value CHF41,255.63 | Price 41.26 | Shares 1,000
Sale 17 Apr 2025
Value CHF118,568.67 | Price 41.26 | Shares 2,874
Sale 17 Apr 2025
Value CHF173,479.91 | Price 41.26 | Shares 4,205
Sale 28 Oct 2024
Value CHF22,500.00 | Price 45.00 | Shares 500
Sale 25 Apr 2024
Value CHF79,966.26 | Price 41.01 | Shares 1,950
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-29 2026-05-29 S Sale Executive Director / Officer
46,674
329.70
CHF4,843,904 		46,674 329.70 CHF4,843,904
2026-05-13 2026-05-13 S Sale Executive Director / Officer
1,466
446.26
CHF3,083,877 		1,466 446.26 CHF3,083,877
2026-04-30 2026-04-30 S Sale Executive Director / Officer
57,490
405.78
CHF2,847,001 		57,490 405.78 CHF2,847,001
2026-04-20 2026-04-20 S Sale Executive Director / Officer
1,000
56.40
CHF56,400 		1,000 56.40 CHF56,400
2026-04-17 2026-04-17 S Sale Executive Director / Officer
1,000
56.00
CHF56,000 		1,000 56.00 CHF56,000
2026-04-15 2026-04-15 S Sale Executive Director / Officer
1,500
10.40
CHF15,600 		1,500 10.40 CHF15,600
2026-02-26 2026-02-26 S Sale Executive Director / Officer
2,000
9.40
CHF18,800 		2,000 9.40 CHF18,800
2026-02-24 2026-02-24 S Sale Executive Director / Officer
1,500
7.20
CHF10,800 		1,500 7.20 CHF10,800
2026-02-20 2026-02-20 S Sale Executive Director / Officer
600
54.68
CHF32,807 		600 54.68 CHF32,807
2025-11-24 2025-11-24 S Sale Executive Director / Officer
600
48.20
CHF28,920 		600 48.20 CHF28,920
2025-09-30 2025-09-30 S Sale Executive Director / Officer
1,200
47.00
CHF56,400 		1,200 47.00 CHF56,400
2025-05-21 2025-05-21 S Sale Executive Director / Officer
600
45.00
CHF27,000 		600 45.00 CHF27,000
2025-04-30 2025-04-30 S Sale Executive Director / Officer
400
44.00
CHF17,600 		400 44.00 CHF17,600
2025-04-23 2025-04-23 S Sale Executive Director / Officer
1,369
41.93
CHF57,396 		1,369 41.93 CHF57,396
2025-04-23 2025-04-23 S Sale Non-Executive Director
730
41.55
CHF30,331 		730 41.55 CHF30,331
2025-04-17 2025-04-17 S Sale Executive Director / Officer
1,000
41.26
CHF41,256 		1,000 41.26 CHF41,256
2025-04-17 2025-04-17 S Sale Executive Director / Officer
2,874
41.26
CHF118,569 		2,874 41.26 CHF118,569
2025-04-17 2025-04-17 S Sale Executive Director / Officer
4,205
41.26
CHF173,480 		4,205 41.26 CHF173,480
2024-10-28 2024-10-28 S Sale Executive Director / Officer
500
45.00
CHF22,500 		500 45.00 CHF22,500
2024-04-25 2024-04-25 S Sale Executive Director / Officer
1,950
41.01
CHF79,966 		1,950 41.01 CHF79,966
Explore more

More insider trading research around Basilea Pharmaceutica AG

More insider trades in Switzerland
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe
Insider trades in Swiss Performance Index